Bilcare clarifies director roles after failed executive appointments

scanx
Reviewed by
Naman SScanX News Team
Key Highlights
  • Special resolutions for Executive Director appointments failed at the 39th AGM
  • Mohan Bhandari remains Non-Executive Non-Independent Director and CEO
  • Kavita Bhansali continues as Non-Executive Non-Independent Director
  • Clarification issued to BSE on October 15, 2026
powered bylight_fuzz_icon
53612350

*this image is generated using AI for illustrative purposes only.

Bilcare Ltd clarified that Mohan Bhandari and Kavita Bhansali continue as Non-Executive Non-Independent Directors following the failure of special resolutions to appoint them as Executive Directors at the annual general meeting.

The company stated that Bhandari retains his role as CEO alongside his directorship, while Bhansali continues solely as a Non-Executive Non-Independent Director. This clarification follows a board meeting held on August 13, 2026, which had initially proposed these appointments.

Resolution outcome

During the 39th Annual General Meeting held on September 26, 2026, shareholders did not pass the requisite majority required for the special resolutions. Consequently, the proposed change in designation from Non-Executive to Executive Director status was not implemented for either individual.

Director Current Designation Proposed Designation (Failed)
Mohan Bhandari Non-Executive Non-Independent Director & CEO Executive Director
Kavita Bhansali Non-Executive Non-Independent Director Executive Director

The company notified the Bombay Stock Exchange under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The disclosure confirms that the initial changes reflected on the BSE portal were provisional pending shareholder approval, which was not secured.

Historical Stock Returns for Bilcare

1 Day5 Days1 Month6 Months1 Year5 Years
-1.42%-3.27%-1.37%+43.88%+43.88%+43.88%

Will Bilcare Ltd seek shareholder approval for executive director appointments again at the next general meeting?

How might the rejection of these resolutions impact investor confidence in Bilcare's corporate governance standards?

What are the potential implications for Bilcare's operational strategy given the continued separation of CEO and Executive Director roles?

Bilcare AGM: Special resolutions on director roles, RPTs defeated

scanx
Reviewed by
Anirudha BScanX News Team
Key Highlights
  • Three special resolutions at Bilcare's 39th AGM were defeated, including executive director appointments for Kavita Bhansali and Mohan Harakchand Bhandari.
  • The proposal to approve material related party transactions with Caprihans India Limited was rejected by 98.44% of valid public votes.
  • Ordinary resolutions for financial statement adoption and director reappointments passed, driven by promoter support and sufficient majority.
powered bylight_fuzz_icon
51976078

*this image is generated using AI for illustrative purposes only.

Bilcare Limited shareholders voted against three special resolutions at the 39th Annual General Meeting held on September 26, 2026. The rejected items included the re-appointment of Kavita Bhansali and Mohan Harakchand Bhandari as Executive Directors, as well as the approval of material related party transactions with Caprihans India Limited.

The scrutiny report by Shekhar Ghatpande confirmed that while ordinary resolutions for financial statement adoption and director reappointments passed with requisite majorities, the special business items failed to secure the necessary votes. This outcome marks a significant divergence in shareholder sentiment regarding the company's executive leadership structure and related party dealings.

Voting results breakdown

The following table summarizes the outcome of the six agenda items transacted during the virtual meeting:

Sr. No. Resolution Description Type Outcome
1 Adoption of Audited Standalone & Consolidated Financial Statements for FY26 Ordinary Passed
2 Re-Appointment of Kavita Bhansali as Director liable to retire by rotation Ordinary Passed
3 Re-Appointment of Kavita Bhansali as Executive Director Special Defeated
4 Appointment of Mohan Harakchand Bhandari as Director liable to retire by rotation Ordinary Passed
5 Appointment of Mohan Harakchand Bhandari as Executive Director Special Defeated
6 Approval of Material Related Party Transactions with Caprihans India Limited Special Defeated

Public shareholder dissent

The defeat of the special resolutions was driven primarily by public non-institutional shareholders. For Resolutions 3, 4, and 5, public shareholders cast approximately 39.78 lakh votes against the proposals, compared to only 1.65 lakh votes in favor. In contrast, the promoter group voted unanimously in favor of these resolutions but could not offset the public opposition due to their lower shareholding percentage among voting participants.

For Resolution 6, concerning related party transactions with Caprihans India Limited, promoter shareholders abstained from voting as they were interested in the matter. Among eligible public shareholders, 98.44% of the valid votes cast were against the resolution, leading to its defeat.

Governance context

The meeting commenced at 2:00 pm IST and concluded at 2:27 pm IST, with 38 members participating via video conferencing. A corrigendum issued on September 24, 2026, had previously corrected a typographical error in the notice regarding Resolution No. 4, clarifying it as an Ordinary Resolution rather than a Special Resolution.

Mohan H. Bhandari, CEO of the company, addressed shareholders following procedural formalities, providing insights into business performance and strategic initiatives. However, the voting outcomes indicate that these assurances did not sway public shareholder opinion on the specific executive appointments and related party approvals.

Historical Stock Returns for Bilcare

1 Day5 Days1 Month6 Months1 Year5 Years
-1.42%-3.27%-1.37%+43.88%+43.88%+43.88%

Will Bilcare Limited initiate a search for independent executive directors to replace the rejected appointments, and how might this impact operational continuity?

How will the rejection of related party transactions with Caprihans India Limited affect Bilcare's supply chain strategy or cost structure in the upcoming fiscal year?

What specific governance reforms or shareholder engagement initiatives is management planning to implement to rebuild trust with public shareholders?

More News on Bilcare

1 Year Returns:+43.88%